glp-1 .25 mg Decoding Weight Loss Medications Ozempic® (semaglutide) GLP-1 RA for

Evidence is preliminary and includes animal studies showing reduced substance-seeking behaviours and observational human data suggesting lower alcohol consumption

The Problems with Current GLP-1 Guidelines Traditional medicine waits to prescribe GLP-1 medications until a patients BMI hits 30 (obesity) or 27 with at least one weight-related health condition, such as high blood pressure or high cholesterol

This activity of GLP-1 has been demonstrated in both preclinical and clinical studies, and the results support the hypothesis that the GLP-1 pathway regulates the processes of alcohol use disorder (AUD)

doi: 10.1016/0014-5793(84)81245-4

Both Ozempic and Wegovy retail at $499/month